Boswellia
Important Disclaimer
This is not medical advice. Consult a qualified healthcare provider before using any remedy, especially if pregnant, breastfeeding, on medication, or managing a health condition.
Overview
Boswellia serrata is a medium-sized deciduous tree native to the dry mountainous regions of India, Pakistan, and Afghanistan, belonging to the same family as the famous African and Arabian frankincense trees. The tree produces an aromatic gum-resin that has been traded and used medicinally for thousands of years in Ayurvedic medicine and Middle Eastern traditions. In the 20th century, Boswellia underwent extensive clinical investigation that revealed its unique anti-inflammatory mechanism: its primary active compounds, boswellic acids (particularly acetyl-keto-beta-boswellic acid, AKBA), inhibit 5-lipoxygenase (5-LOX) — the enzyme responsible for producing pro-inflammatory leukotrienes — through a novel mechanism distinct from both NSAIDs and corticosteroids. This discovery sparked intense clinical research, and today Boswellia has robust clinical evidence for osteoarthritis, inflammatory bowel disease, and asthma.
Traditional Use
Boswellia serrata has been used in Ayurvedic medicine for at least 3,000 years, where it is known as Shallaki. Classical Ayurvedic texts including the Charaka Samhita and Sushruta Samhita describe its use for arthritis (ama vata), diarrhea, dysentery, pulmonary conditions, and wound healing. It is classified as a tridoshic herb that primarily pacifies Kapha and Vata. The Ayurvedic indication for joint diseases — particularly inflammatory arthritis — aligns precisely with the modern clinical evidence. In Islamic and Middle Eastern medicine, frankincense resin (both from Boswellia serrata and B. sacra) has been a cornerstone of traditional medicine for over 2,000 years. Arab and Persian physicians including Avicenna (Ibn Sina) in the Canon of Medicine (1025 CE) described frankincense for inflammatory conditions, respiratory ailments, and wound healing. The spiritual and ceremonial use of Boswellia resin as incense spans multiple ancient civilizations — from ancient Egypt, where it was burned in temple ceremonies and used in embalming, to the Christian and Jewish traditions where frankincense was considered one of the most precious gifts (the Magi's gift to the Christ child). In Chinese medicine, various Boswellia species (known as Ru Xiang) have been used for blood circulation disorders, pain, and wound healing. In Ethiopian traditional medicine, Boswellia papyrifera resin is used for numerous ailments. The modern clinical development of Boswellia began when Indian Ayurvedic research institutions began investigating the pharmacology of Shallaki in the 1980s, leading to isolation of boswellic acids and the first clinical trials for arthritis in the 1990s.
Key Active Compounds
Acetyl-11-Keto-Beta-Boswellic Acid (AKBA)
The most pharmacologically potent boswellic acid — a specific, competitive, non-redox inhibitor of 5-lipoxygenase (5-LOX), the enzyme producing pro-inflammatory leukotrienes (LTB4). Unlike NSAIDs (which inhibit COX enzymes), AKBA targets the leukotriene pathway, explaining Boswellia's efficacy in inflammatory conditions with strong leukotriene components (asthma, IBD). AKBA also inhibits NF-kB and cathepsin G.
Beta-Boswellic Acid and Keto-Beta-Boswellic Acid
The most abundant boswellic acids, contributing to 5-LOX inhibition and additional anti-inflammatory activity through complement pathway inhibition and leukocyte elastase inhibition. Synergistic with AKBA for overall anti-inflammatory effects.
Incensole Acetate
A unique diterpene found in Boswellia resin with neuroprotective and anxiolytic properties — inhibits TRPV3 channels and activates TRPV3-dependent signaling. This compound is responsible for the psychoactive effects of frankincense incense described in religious and meditative practices, and is being studied for neurological and mood disorders.
Alpha and Beta-Pinene (Essential Oil)
Monoterpene hydrocarbons contributing to the characteristic piney-balsamic aroma and providing additional anti-inflammatory and antimicrobial activity. The essential oil fraction varies significantly between Boswellia species.
Evidence-Based Benefits
Osteoarthritis and Joint Health
Strong evidenceMultiple RCTs demonstrate significant reduction in pain, stiffness, and disability in knee osteoarthritis. A landmark 2003 RCT in the journal Phytomedicine showed 56% of patients receiving Boswellia extract reported improvement vs 10% placebo. A 2014 systematic review in the Journal of Pharmacy and Pharmacology confirmed efficacy across multiple trials. Standardized extracts (particularly those enriched in AKBA, such as 5-LOXIN) outperform standard extracts.
Inflammatory Bowel Disease (IBD)
Strong evidenceMultiple clinical trials demonstrate Boswellia's efficacy in Crohn's disease and ulcerative colitis. A German clinical trial showed Boswellia extract (H15) equivalent to mesalazine for maintaining Crohn's remission. The leukotriene-inhibiting mechanism is particularly relevant for IBD, where LTB4 is a major driver of intestinal inflammation. Clinical studies also show benefit in microscopic colitis.
Asthma and Respiratory Inflammation
Moderate evidenceClinical studies show Boswellia reduces asthma attacks, improves lung function, and reduces eosinophil count in bronchial asthma patients. The 5-LOX inhibition mechanism is directly relevant to asthma (LTC4, LTD4, and LTE4 are key mediators of bronchoconstriction). A 1998 clinical study showed 70% of Boswellia-treated asthma patients improved vs 27% placebo.
Rheumatoid Arthritis and Inflammation
Moderate evidenceClinical studies demonstrate reduction in inflammatory markers, morning stiffness, and joint tenderness in rheumatoid arthritis. Laboratory evidence also supports benefits in other inflammatory conditions including tendinitis and inflammatory skin conditions. The unique 5-LOX mechanism is complementary to conventional NSAID therapy.
Common Preparation Methods
Standardized Extract (Most Effective — Joint/IBD)
Use a standardized Boswellia extract specifying boswellic acid content. Look for products with minimum 65% total boswellic acids and at least 10% AKBA (the most active compound).
Dosage: 300–400mg three times daily with foodThis is the form used in clinical trials. Total daily dose of 900–1200mg of standardized extract (equivalent to approximately 450–600mg boswellic acids). AKBA-enriched products (such as 5-LOXIN at 100mg/day or Aflapin at 100mg/day) have shown equivalent efficacy at lower doses. Take with food — fat enhances absorption of boswellic acids significantly. Allow 4–8 weeks for full therapeutic effect.
Raw Resin Chewing (Traditional Ayurvedic)
Chew a small piece of Boswellia resin (approximately 1g) like chewing gum for 15–20 minutes, then discard. This is the traditional Ayurvedic method.
Dosage: 1–2g resin chewed 2–3 times daily between mealsTraditional Ayurvedic administration. The resin has a pleasant, balsamic taste initially turning slightly bitter. Swallowing the resin is acceptable at these doses. Less reliably dosed than standardized extracts but the whole resin contains the complete natural compound profile. Best Boswellia resin is pale yellow to golden; avoid dark, overly dried specimens.
Topical Application
Apply Boswellia-infused cream or oil (5% Boswellia extract) to affected joints. Massage gently for 2–3 minutes.
Dosage: Apply 2–3 times daily to affected areasEffective topical option for localized arthritis pain. Clinical studies confirm topical Boswellia reduces knee osteoarthritis pain. Combine with oral supplementation for maximum effect. Boswellia-containing topical preparations are widely available in health stores.
Safety & Cautions
Please read carefully before use
Contraindications
- Pregnancy — insufficient safety data; avoid therapeutic doses
- Severe kidney or liver disease — use with caution; limited data
- Allergy to Burseraceae family (frankincense, myrrh)
Drug Interactions
- Anticoagulants (warfarin, heparin) — may affect coagulation; monitor
- NSAIDs and aspirin — complementary mechanisms; generally safe combination but monitor GI tolerance
- Cytochrome P450 substrates — some boswellic acids may affect CYP450 enzymes; consult pharmacist
- Immunosuppressants — additive anti-inflammatory effects; consult physician
Possible Side Effects
- Generally well-tolerated with an excellent safety record in clinical trials
- Most common: mild GI discomfort, nausea, diarrhea — take with food
- Skin rash or allergic reactions — rare
- Headache — occasional at high doses
- Long-term safety (beyond 6 months) not fully established in clinical trials
Special Populations
- Avoid during pregnancy without specialist supervision
- Safe for adults at standard doses for up to 6 months (the period studied in most trials)
- Excellent option for elderly patients with arthritis as an alternative or adjunct to NSAIDs with better GI safety profile
- Children: insufficient pediatric data — consult pediatrician
- No significant concerns in breastfeeding at oral supplemental doses, but data limited
Sources & References
Journal of Pharmacy and Pharmacology
European Journal of Medical Research
Quick Reference
Burseraceae
Resin (gum/oleoresin), Bark extract, Standardized extract (AKBA-enriched)
Bitter, slightly pungent, resinous; the raw resin is strongly aromatic with a balsamic, slightly citrus-pine character
Safety First
Always consult with a qualified healthcare provider before starting any new remedy, especially if you have existing health conditions or take medications.
